$40M in seed investments leverages 19x new capital into Ontario cancer biotechnology commercialization
FACIT’s network of industry partners and investors are becoming increasingly aware of the top-tier quality of Ontario’s innovations, which has been integral in attracting the $750M follow-on investment.
